HBIO
Harvard Bioscience, Inc. · Healthcare
Director Bertrand Loy bought $93K of Harvard Bioscience, Inc.
Bought$92,686
$2.56Price
36,150Shares
+16%Stake
What HBIO did for a copier
Prices for HBIO after this filing aren't in yet.
Bertrand Loy's record
4 other buys with 3 months of prices since 2019: on average −26.7% against the S&P 500, and 0 of 4 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Nov 8. Filed Wed, Nov 13, 4:30 PM ET, after the close. Not investment advice.